Table 6 Data from the published ASV-real-life and non comparative studies (only studies with more than 70 patients were included; data concern the whole population)
| Â | N / C | Main sub-groups analysis reported | Prevalence of related SA comorbidity/etiology | CPAP trial before ASV | Duration of ASV / ASV-adherence | Initial AHI/h / Final AHI/h or AHIflow/h | Initial Epworth / Final Epworth |
|---|---|---|---|---|---|---|---|
Carnevale et al., 2011 [10]. Retrospective | 74 / 2 | 55% non-CHF and 45% CHF | NA CHF with LVEF≤45% NA CHF with LVEF> 45% 17% N, NA R, NA O, 28% I | 15/74 patients Duration of the trial NA | 36 ± 18 months / 75.6% > 3 h/jour | 53.0 ± 23.8/h / 5.9 ± 8.0/h | 8.9 ± 5.3 / NA |
Momomura et al., 2015 [11]. Retrospective | 115 / 16 | 24% ASV-discontinued CHF and 76% ASV-continued CHF | NA CHF (LVEF≤45%) NA CHF (LVEF> 45%) NA N, NA R, NA O, NA I | No CPAP trial | NA / NA | 28.8 ± 19.2/h for ASV-discontinued CHF and 24 ± 21.3/h for ASV-continued CHF/NA | NA / NA |
Malfertheiner et al., 2017 [12]. Retrospective | 285 / 2 | 32% Cardiac center 68% Pulmonary center | 39% CHF with LVEF≤45% 40% CHF with LVEF> 45% 0% N, NA R, 0.4% O, 10% ICSA | 1 night for 86 CSA patients and median trial of 17 days for 178 OSA patients | NA / NA | NA / NA | 9 ± 4.5 / NA |
Randerath et al., 2017 [13]. Retrospective | 293 / 1 | 57% CSA, 36% OSA, and presence of risk criteria (LVEF ≤45% and CSA) | 16% CHF with LVEF≤45% 23% CHF with LVEF> 45% NA N, NA R, 8% O, NA I | NA | NA / NA | 46.4 ± 20.5/h / NA | 7.8 ± 4.5 / 5.4 ± 3.7 |
Oldenburg et al., 2019 [8]. Retrospective | 224 / 1 | 100% CHF and LVEF ≤45% and AHI ≥ 15/h with predominant central pattern | NA | No CPAP trial | 24 months 65.9% > 4 h/day at 24 months | 37.7 ± 13.4 / 2.8 ± 3.2/h at 24 months | NA / NA |
Jaffuel et al. Prospective | 177 / 5 | 59.3% CSA, 20.3% OSA, 20.3% TECSA (11 patients with LVEF≤45% and CSA were excluded) | 7.3% CHF with LVEF≤45% 51.4% CHF with LVEF> 45% 12.4% N, 4.5% R, 3.4% O, 9.6% I | 91/177 Duration of the trial NA | 34.5 (21.1–59.5) months / 87% > 4 h/day | 50/h (38–62) / 1.9/h (0.7–3.8) | 10 (6–13.5) / 6 (3–9) |